Le Lézard
Classified in: Covid-19 virus
Subjects: BFA, CSR

Free TutorCams for 100 Heroic Teachers


LOS ANGELES, Oct. 13, 2020 /PRNewswire/ -- It is time to say thanks to our amazing teachers. TutorCam inventor Brandon Kennington has announced a major giveaway to honor teachers for their dedication in virtual classrooms during the COVID-19 pandemic.

Brandon is giving free TutorCam Go devices to 100 teachers in an event dubbed: One Hundred Heroes.

Tell us about a teacher who could benefit from a free TutorCam Go.

Brandon, a dad and mechanical engineer, invented the TutorCam (www.tutorcampro.com) after helping teach a math class over Google Meet at his kids' Los Angeles elementary school in the early days of the pandemic in March. He saw a need for an easy-to-use document camera to supplement remote learning classes.

"Teachers are superheroes," Brandon, a Purdue University graduate, said.

"The pandemic quickly shut schools and teachers had to respond instantly, with many facing technological issues and often paying for equipment out of their own pocket to ensure they connect with their students.

"Teachers are amazing, and I want to show my gratitude by giving away 100 TutorCams to teachers who really need them."

TutorCams were an instant sensation when they hit the market in August. NBC's Today Show declared them a "must-have" in a segment hosted by style expert Jenn Falik.

Teachers and students usually can only see each other's faces during remote learning. TutorCams have a special optical lens to focus on documents, workbooks etc. on their desk by using a mobile phone or tablet camera.

TutorCams do not need an app or additional software. TutorCams work with Zoom, Google Meet, Microsoft Teams, Skype and other video conferencing platforms. 

The One Hundred Heroes giveaway begins October 13 and ends October 27.

Do you know a teacher who has struggled with tech, budget or other issues and could benefit from a free TutorCam Go? Tell us her/his story.

In your entries please tell us the teacher's name, school, state and why you believe she/he deserves a free TutorCam Go. There are several ways to enter.

Email us at [email protected] or fill out this entry form: https://tutorcampro.com/pages/100-heroes

You can also enter by posting on our @TutorCam Facebook, Instagram, and Twitter pages. Be sure to tag or @ mention us and use the hashtags #onehundredheroes #100Teacher #TutorCam to make sure we see your post. Winners will be posted on our social media.

MEDIA CONTACT:
Peter Mitchell
Email: [email protected]  
Phone: 310 941-7714

MARKETING CONTACT:
Maria Elena
Email: [email protected]  
Phone: 432 235-0597

SOURCE TutorCam


These press releases may also interest you

at 01:20
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

18 avr 2024
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: